A Phase I Study Of Decitabine (DAC) (IND50733) In Children With Relapsed Or Refractory Acute Leukemia
Phase of Trial: Phase I
Latest Information Update: 22 Jan 2013
At a glance
- Drugs Decitabine (Primary)
- Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia
- Focus Adverse reactions; Biomarker; Pharmacogenomic; Pharmacokinetics; Therapeutic Use
- 22 Jan 2013 Actual initiation date changed from Jan 2003 to Dec 2002 as reported by ClinicalTrials.gov.
- 22 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 04 Jun 2007 Status changed from in progress to completed.